HIVE Stock Slips As Analyst Cuts Price Target

HIVE Digital Technologies Ltd faces pressure as key crypto market headwinds intensify, with stocks have been trading down by -3.99 percent.

Spot the Next Big Runner

Click Here for a Millionaire's POV on Trading HIVE

SUBSCRIBE FOR ALERTS

JOIN 50,000+ ACTIVE TRADERS

Key Takeaways

Keefe Bruyette cut HIVE Digital’s price target from $5.00 to $4.50 but kept a Market Perform rating in place.
Analysts remain upbeat on high-performance computing (HPC) colocation demand supporting HIVE’s long-term story.
Funding needs and AI-tenant business model risk sit at the center of their caution on HIVE.
Recent HIVE share weakness is framed as a valuation reset tied to the project pipeline, not a collapse in asset quality.

Live Update At 15:02:45 EDT: On Friday, August 21, 2026 HIVE Digital Technologies Ltd stock [NASDAQ: HIVE] is trending down by -3.99%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

HIVE Digital Technologies Ltd is trading like a classic battleground name. The daily chart shows HIVE bouncing around the low-$3 area, closing at about $3.01 after dipping to $2.95 and touching $3.31 in the premarket range. Over the last few weeks, HIVE has swung between roughly $2.53 and $3.30, a tight but active range that tells traders there is steady two-sided interest.

On the intraday 5‑minute chart, HIVE spent most of the day grinding lower from the low-$3.20s at the open toward the $3.00 level, with a heavy fade after the morning push. That kind of intraday action often signals supply waiting above $3.20 and short-term support just under $3.00, giving day traders clear lines to map risk.

More Breaking News

Fundamentally, HIVE reported about $79.1M in quarterly revenue and roughly $297.8M over the trailing twelve months, yet the company is still losing money. Gross margin is negative at around -17%, and EBIT margin is deeply negative, above -80%. HIVE is funding its pivot into HPC and AI infrastructure through debt and equity, with total debt-to-equity at 0.84 but a solid current ratio near 2. For active traders, that mix of strong top-line growth, weak profitability, and reasonable liquidity creates a textbook “story stock” setup: plenty of volatility, but also real execution risk.

Why Traders Are Watching HIVE After The Target Cut

HIVE Digital is back in focus after Keefe Bruyette trimmed its price target from $5.00 to $4.50 and reaffirmed a Market Perform rating. For traders, that is not a bullish stamp of approval, but it is far from a downgrade disaster. The key message is that HIVE’s long-term high-performance computing colocation story still stands, yet the path is messier and more funding-dependent than the market previously priced in.

The firm’s note leans on one clear positive: demand for HPC colocation capacity. As AI workloads grow, data centers that can host GPU-heavy tenants get a structural tailwind. HIVE Digital is positioning its infrastructure to grab that demand. That helps explain why, even with heavy losses and negative margins, the stock still commands a price-to-sales multiple around 1.6 and a price-to-book near 1.8. Traders are paying for optionality on HIVE’s future cash flows, not its current bottom line.

But Keefe Bruyette is also flagging the real risks. HIVE must fund ongoing buildouts, and its latest cash flow numbers show heavy reliance on debt issuance and stock sales. In the most recent quarter, HIVE generated only about $4.1M in operating cash flow, yet raised roughly $199.2M in new long-term debt and $30.0M from common stock issuance. At the same time, HIVE’s net income from continuing operations was a steep loss of about $142.9M.

Layer on top the AI-tenant model risk the analyst mentions. If HIVE signs tenants whose own AI business models are unproven, it faces counterparty risk just as it ramps capex. That combo of funding needs and tenant quality questions explains why HIVE shares have weakened and why the target moved down. The story is alive, but traders now demand a bigger discount while they wait to see execution.

Conclusion

For active traders, HIVE Digital Technologies Ltd sits in the classic gray zone between hype and proof. The Market Perform rating from Keefe Bruyette tells you the stock is in valuation reset mode, not freefall. HIVE still has tangible assets — about $559.6M in property, plant, and equipment and roughly $208.0M in cash — plus a real pipeline in HPC colocation. That’s the backbone supporting the idea that recent share weakness is about repricing, not a broken business.

At the same time, the numbers force discipline. Negative gross margins, negative EBIT, and an $142.9M quarterly loss mean HIVE must rely on capital markets while it chases AI and HPC upside. If credit tightens or equity markets sour, funding risk becomes more than a line in an analyst note. The AI-tenant model risk is just as real; bad counterparties or failed AI projects can leave racks underutilized and debt still ticking.

For traders who study HIVE’s chart and filings, this is the kind of setup that can reward preparation. As Tim Sykes often says, “The market rewards those who are prepared, not those who are hopeful.” That philosophy lines up with a more tactical trading mindset: you want a clearly defined edge before you hit the buy or sell button. As Tim Bohen, lead trainer with StocksToTrade says, “If you’re still guessing at the end of your analysis, it’s probably not a trade worth taking.”. HIVE Digital will likely stay a volatile name around headlines, financing deals, and new HPC contracts. Use that volatility as an educational lab: map your levels, track the fundamentals quarter by quarter, and treat every trade in HIVE as research, not a long-term promise.

This is stock news, not investment advice. StocksToTrade News delivers real-time stock market updates tailored to highlight the key catalysts driving short-term price movements. Our coverage is designed for active traders and investors who thrive in fast-moving markets, with a focus on volatile sectors like penny stocks, AI stocks, Robinhood stocks and other momentum plays. From earnings reports and FDA approvals to mergers, new contracts, and unusual trading volume, we break down the events that can spark significant price action.

Looking to level up your trading game? Explore StocksToTrade, the ultimate platform for traders. With powerful tools designed for swing and day trading, integrated news scanning, and even social media monitoring, StocksToTrade keeps you one step ahead.

Check out our quick startup guide for new traders!

Ready to build your watchlists? Check out these curated lists:

Once your watchlist is set, take the next step and trade with confidence using StocksToTrade’s robust platform. Don’t miss out — grab your 14-day trial for just $7 and experience the edge you need to thrive in today’s fast-paced markets.

Start Your Trial Now!